Blockade of TNF in vivo using cV1q antibody reduces contractile dysfunction of skeletal muscle in response to eccentric exercise in dystrophic mdx and normal mice
| dc.contributor.author | Piers, A. | |
| dc.contributor.author | Lavin, T. | |
| dc.contributor.author | Crabb, Hannah | |
| dc.contributor.author | Bakker, A. | |
| dc.contributor.author | Grounds, M. | |
| dc.contributor.author | Pinniger, G. | |
| dc.date.accessioned | 2017-01-30T13:25:20Z | |
| dc.date.available | 2017-01-30T13:25:20Z | |
| dc.date.created | 2014-11-19T01:13:20Z | |
| dc.date.issued | 2011 | |
| dc.identifier.citation | Piers, A. and Lavin, T. and Crabb, H. and Bakker, A. and Grounds, M. and Pinniger, G. 2011. Blockade of TNF in vivo using cV1q antibody reduces contractile dysfunction of skeletal muscle in response to eccentric exercise in dystrophic mdx and normal mice. Neuromuscular Disorders. 21: pp. 132-141. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/31439 | |
| dc.publisher | Elsevier Science B.V. | |
| dc.title | Blockade of TNF in vivo using cV1q antibody reduces contractile dysfunction of skeletal muscle in response to eccentric exercise in dystrophic mdx and normal mice | |
| dc.type | Journal Article | |
| dcterms.source.volume | 21 | |
| dcterms.source.startPage | 132 | |
| dcterms.source.endPage | 141 | |
| dcterms.source.issn | 09608966 | |
| dcterms.source.title | Neuromuscular Disorders | |
| curtin.accessStatus | Fulltext not available |